| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,175,956 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baldino Frank Jr |
Chairman & CEO |
• • – |
2006-12-22 |
4 |
S |
$69.25 |
$1,385,000 |
D/D |
(20,000) |
374,161 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-21 |
4 |
S |
$69.75 |
$348,750 |
D/D |
(5,000) |
47,825 |
|
- |
|
| Osborn John E |
Exec. VP & General Counsel |
• – – |
2006-12-21 |
4 |
S |
$70.00 |
$561,820 |
D/D |
(8,026) |
39,000 |
|
- |
|
| Osborn John E |
Exec. VP & General Counsel |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
47,026 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President and CFO |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
94,734 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
59,761 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
397,188 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
20 |
52,825 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2006-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,027 |
394,161 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,845 |
|
- |
|
| Savini Carl A |
Exec VP & Chief Admin Officer |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
47,326 |
|
- |
|
| Vaught Jeffry L |
Exec. Vice Pres. & Pres., R&D |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
56,887 |
|
- |
|
| Russell Lesley |
Exec VP, WW Med. & Reg. Ops. |
• – – |
2006-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
18,836 |
|
- |
|
| Osborn John E |
Exec. VP & General Counsel |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$194,436 |
D/D |
(2,732) |
32,026 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President and CFO |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$194,436 |
D/D |
(2,732) |
79,734 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$179,775 |
D/D |
(2,526) |
44,761 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2006-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
560 |
317,188 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2006-12-18 |
4 |
D |
$71.17 |
$937,594 |
D/D |
(13,174) |
317,748 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$176,857 |
D/D |
(2,485) |
37,845 |
|
- |
|
| Savini Carl A |
Exec VP & Chief Admin Officer |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$179,775 |
D/D |
(2,526) |
32,326 |
|
- |
|
| Vaught Jeffry L |
Exec. Vice Pres. & Pres., R&D |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$176,857 |
D/D |
(2,485) |
41,887 |
|
- |
|
| Russell Lesley |
Exec VP, WW Med. & Reg. Ops. |
• – – |
2006-12-18 |
4 |
D |
$71.17 |
$8,754 |
D/D |
(123) |
3,836 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
40 |
40,330 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
10 |
40,370 |
|
- |
|
| Osborn John E |
Exec. VP & General Counsel |
• – – |
2006-12-01 |
4 |
D |
$75.00 |
$93,150 |
D/D |
(1,242) |
34,758 |
|
- |
|
491 Records found
|
|
Page 12 of 20 |
|
|
